Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (849)
Cancellation by sponsor (780)
Prescription medicine registration (54)
Cancellation or suspension (44)
Australian Public Assessment Report (AusPAR) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2024 (18)
2023 (84)
2022 (230)
2021 (265)
2020 (113)
2019 (35)
2018 (66)
2017 (364)
2016 (34)
2015 (22)
2014 (48)
2013 (40)
2012 (61)
2011 (28)
2010 (46)
2009 (25)
2008 (10)
2007 (28)
2006 (6)
2005 (17)
2004 (15)
2003 (33)
2002 (15)
2001 (4)
2000 (14)
1999 (9)
1998 (8)
1997 (11)
1996 (10)
1995 (7)
1994 (6)
1993 (12)
1992 (11)
1991 (41)

Results for "[search-keyword]"

Search

Sponsor content

1736 result(s) found, displaying 91 to 100

ARIANNA anastrozole 1 mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
PANTOPRAZOLE MYL pantoprazole (as sodium sesquihydrate) 40 mg enteric-coated tablet blister pack. Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
PANTOPRAZOLE MYL pantoprazole (as sodium sesquihydrate) 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
PANTOPRAZOLE MYLAN pantoprazole 20mg (as sodium sesquihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DIZOLE 150 fluconazole 150 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
NUFLOXIB norfloxacin 400 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
HYSODERM CREAM hydrocortisone acetate 10 mg/g tube Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
NCHA NICOTINE STEP 3 NICOTINE PATCHES 7mg/24 hours nicotine 17.5mg transdermal drug delivery system Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
NCHA NICOTINE STEP 2 NICOTINE PATCHES 14mg/24 hours nicotine 35mg transdermal drug delivery system Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
NCHA NICOTINE STEP 1 NICOTINE PATCHES 21mg/24 hours nicotine 52.5mg transdermal drug delivery system Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.